AC Immune SA Ret. em ativos
Qual é o Ret. em ativos de AC Immune SA?
O Ret. em ativos de AC Immune SA é -31.89%
Qual é a definição de Ret. em ativos?
Retorno sobre os ativos indica como os ativos de uma empresa são lucrativos na geração de receita. É calculado dividindo-se o lucro líquido pelo total de ativos médios.
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. em ativos de empresas na Setor Health Care em NASDAQ em comparação com AC Immune SA
O que AC Immune SA faz?
ac immune is a clinical-stage swiss-based biopharmaceutical company, listed on nasdaq, which aims to become a global leader in precision medicine for neurodegenerative diseases. the company designs, discovers and develops therapeutic as well as diagnostic products intended to prevent and modify diseases caused by misfolding proteins. ac immune’s two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as alzheimer’s disease (ad). the company’s pipeline features nine therapeutic and three diagnostic product candidates – with five product candidates currently in clinical trials. the most advanced of these is crenezumab, a humanized anti-amyloid-β monoclonal igg4 antibody that targets monomeric and aggregated forms of amyloid-β, with highest affinity for neurotoxic oligomers. crenezumab is currently in two phase 3 clinical studies for ad, under a global program conducted by the collabor
Empresas com ret. em ativos semelhantes a AC Immune SA
- Genetic Signatures tem Ret. em ativos de -31.96%
- Environmental Clean Technologies tem Ret. em ativos de -31.94%
- Dash Capital Corp tem Ret. em ativos de -31.93%
- Exore Resources tem Ret. em ativos de -31.93%
- Trafalgar Property plc tem Ret. em ativos de -31.91%
- Doumob tem Ret. em ativos de -31.89%
- AC Immune SA tem Ret. em ativos de -31.89%
- CFI-Compagnie Fonciere Internationale tem Ret. em ativos de -31.88%
- Small Pharma Inc tem Ret. em ativos de -31.86%
- Centaurus Metals tem Ret. em ativos de -31.86%
- Musee Grevin SA tem Ret. em ativos de -31.86%
- Creades AB tem Ret. em ativos de -31.85%
- MeiraGTx plc tem Ret. em ativos de -31.85%